Oculis
of patients achieve line improvement in at week vision gainers analysis at week | Oculis
Company
Deck Type
Deck date
May 2023
Slide
16 of 30
Similar slides by Oculis
See diffirences between slides (animation)
Investor Presentation
July 2023
reduction in achieved with sustained to week | Oculis
Investor Presentation
July 2023
reduction in achieved with at week rit | Oculis
Investor Presentation
July 2023
of patients with line improvement in at week | Oculis
Investor Presentation
July 2023
of patients achieve line improvement in at week | Oculis
Related slides by other companies
Neumora Therapeutics
IPO
September 2023
demonstrated statistically significant and clinically meaningful improvements in depression and anhedonia despite inclusion of mild patients | Neumora Therapeutics
Theravance Biopharma
Investor Conference
November 2022
improvements in plasma were seen in patients with | Theravance Biopharma
ATAI
Investor Presentation
January 2024
core study weeks phase a is an open label in patients | ATAI
Kymera
Results
December 2022
summary of data from patients enrolled in | Kymera
Other recent decks by Oculis
See all presentations (6 decks)
Results
August 2023
Investor Presentation
July 2023
Investor Conference
June 2023
Investor Presentation
April 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io